Cargando…
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
OBJECTIVE: To investigate the diagnostic yield of commercial immunodots to detect onconeural antibodies associated with paraneoplastic neurologic syndromes (PNSs), we analyzed the proportion of confirmed positive results using alternative techniques. METHODS: Sera (n = 5,300) of patients with suspec...
Autores principales: | Déchelotte, Benoît, Muñiz-Castrillo, Sergio, Joubert, Bastien, Vogrig, Alberto, Picard, Géraldine, Rogemond, Véronique, Pinto, Anne-Laurie, Lombard, Christine, Desestret, Virginie, Fabien, Nicole, Honnorat, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136063/ https://www.ncbi.nlm.nih.gov/pubmed/32170044 http://dx.doi.org/10.1212/NXI.0000000000000701 |
Ejemplares similares
-
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020) -
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020) -
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies
por: Simard, Claire, et al.
Publicado: (2020) -
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis
por: Villagrán-García, Macarena, et al.
Publicado: (2023) -
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2019)